Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Prohibition of Routine Ascites Production of Monoclonal Antibodies in the United States: A Successful Application of the Alternatives Approach to Biomedical Research

The Prohibition of Routine Ascites Production of Monoclonal Antibodies in the United States: A... ATLA 28, 725–729, 2000 725 Comment The Prohibition of Routine Ascites Production of Monoclonal Antibodies in the United States: A Successful Application of the Alternatives Approach to Biomedical Research John E. McArdle Alternatives Research & Development Foundation, 14280 Golf View Drive, Eden Prairie, MN 55346, USA It has been more than 25 years since George decades following the original discovery, tens Kohler and Cesar Milstein published a short of millions of mice and rats suffered and scientific paper (1) describing their new died, although viable humane alternatives method for producing monoclonal antibodies were readily available. (mAbs). This revolutionary technique was During the same period, the appropriate- adopted in virtually every field of biomedical ness of using the ascites method was research and biotechnology, as well as in increasingly questioned in Europe. Milstein many areas of clinical diagnosis and treat- noted that “in later years, on both practical ment. It also created a major problem in rela- and humane grounds, I became concerned tion to the care and use of laboratory rats with the use of ascitic fluids” (personal com- and mice. munication). As new in vitro replacement Although the original method was princi- alternative techniques were developed and pally http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alternatives to Laboratory Animals SAGE

The Prohibition of Routine Ascites Production of Monoclonal Antibodies in the United States: A Successful Application of the Alternatives Approach to Biomedical Research

Alternatives to Laboratory Animals , Volume 28 (5): 5 – Sep 1, 2000

Loading next page...
 
/lp/sage/the-prohibition-of-routine-ascites-production-of-monoclonal-antibodies-M39eTsAGVq

References (3)

Publisher
SAGE
Copyright
© 2000 Fund for the Replacement of Animals in Medical Experiments
ISSN
0261-1929
eISSN
2632-3559
DOI
10.1177/026119290002800502
Publisher site
See Article on Publisher Site

Abstract

ATLA 28, 725–729, 2000 725 Comment The Prohibition of Routine Ascites Production of Monoclonal Antibodies in the United States: A Successful Application of the Alternatives Approach to Biomedical Research John E. McArdle Alternatives Research & Development Foundation, 14280 Golf View Drive, Eden Prairie, MN 55346, USA It has been more than 25 years since George decades following the original discovery, tens Kohler and Cesar Milstein published a short of millions of mice and rats suffered and scientific paper (1) describing their new died, although viable humane alternatives method for producing monoclonal antibodies were readily available. (mAbs). This revolutionary technique was During the same period, the appropriate- adopted in virtually every field of biomedical ness of using the ascites method was research and biotechnology, as well as in increasingly questioned in Europe. Milstein many areas of clinical diagnosis and treat- noted that “in later years, on both practical ment. It also created a major problem in rela- and humane grounds, I became concerned tion to the care and use of laboratory rats with the use of ascitic fluids” (personal com- and mice. munication). As new in vitro replacement Although the original method was princi- alternative techniques were developed and pally

Journal

Alternatives to Laboratory AnimalsSAGE

Published: Sep 1, 2000

There are no references for this article.